期刊文献+

Flt3配体重组腺病毒感染胃癌细胞的体外研究

Flt3 Ligand Gene Infection of MFC in Vitro Mediated by Recombinant Adenovirus Vector
下载PDF
导出
摘要 目的 研究Flt3配体重组腺病毒(AdmFL)体外感染前小鼠前胃癌细胞的情况。方法 体外分别以不同MOI(mutiplicity of infection)的AdmFL感染胃癌细胞,荧光显微镜下计算感染率,对体外感染后的胃癌细胞连续计数并绘制生长曲线,RT-PCR检测转染后的细胞内mRNA表达,ELISA法检测培养上清中mFl蛋白的浓度。结果 MOI为10、100、500的AdmFL感染小鼠胃癌细胞,荧光显微镜下2 d后根据GFP的表达计算的感染率分别是5%、60%和98%;以MOI为100的AdmFL对体外感染后的胃癌细胞无直接的生长抑制作用;在感染后的胃癌细胞内RT-PCR扩增到了mFL的mRNA,ELISA法检测到mFL蛋白的浓度为60.3±5.2 ng/ml。结论 Flt3配体重组腺病毒能有效地感染小鼠前胃癌细胞,并能介导所携带的mFL高效表达。 Objective To study Flt3 ligand gene infection of MFC in vitro mediated by recombinant adenovirus vector. Method In vitro infection of murine gastric carcinoma cell line MFC with AdmFL at MOI 10、100 and 500, respectively, measured by GFP expression. The mRNA was detected by RT-PCR. The level of mFL protein was check out by ELISA. Results In vitro Infection with AdmFL at MOI 10、100 and 500, was able to lead to 5%、60% and 95% infection rate respectively. There was no direct growth inhibition on MFC infected by AdmFL at MOI 100. The mFL protein was 60.3±5. 2 ng/ml in the infected MFC cell culture supernatant. Conclusion All data suggest AdmFL can infect MFC efficiently and mediate the expression of mFL in vitro.
作者 匡玉庭 赵华
出处 《苏州大学学报(医学版)》 CAS 2004年第6期805-807,共3页 Suzhou University Journal of Medical Science
基金 苏州大学附属一院科研基金课题
关键词 FLT3配体 腺病毒 胃癌 基因治疗 Flt3 ligand adenovirus gastric carcinoma gene therapy
  • 相关文献

参考文献10

  • 1Rosnet O, Machetto S, de Lapeyrirere O, et al. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PGF R/C5FI R family[J].Oncogene,1991,6:1641-1650.
  • 2Lyman SD, James L, Vanden Bos T, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoitic cells[J]. Cell,1993,75:1157-1167.
  • 3Borges L, Miiler RE, Jones J, et al. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumer immunity in vivo[J]. J Immunol,1999,163:1289-1297.
  • 4Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified[J]. J Exp Med, 1996, 184(5):1953-1962.
  • 5Shaw SG, Maung AA, Steptoe RJ, et al. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy[J]. J Immunol, 1998, 161(6): 2817-2824.
  • 6Lynch DH, Andreasen A, Maraskovsky E, et al. F1t3 ligand induces tumor regression and antitumor immune responses in vivo[J]. Nat Med, 1997,3(6): 625-631.
  • 7Esche C, Subbotin VM, Maliszewski C, et al. Flt3 ligand administration inhibits tumor growth in murine melanoma and lymphoma[J]. Cancer Res, 1998,58(3):380-383.
  • 8Braun SE,Chen K, Blazar BR. Flt3 ligand antitumer activity in a murine breast cancer model: a comparison with granulocyte-macrophage colony-stimulating factor and a potential mechanism of action[J]. Human Gene Ther,1999 ,10(13):2141-2151.
  • 9Chen K, Braun S, Lyman S, et al. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model[J]. Cancer Res, 1997, 57(16): 3511-3516.
  • 10Wang A, Braun SE, Sonpavde G, et al. Antileukemic activity of Flt3 ligand in murine leukemia[J]. Cancer Res, 2000, 60(7):1895-1900.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部